PATENT CLAIM ANALYSIS

Application Number: 15756798
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["536", "023100"]

Abstract:
The invention relates to a combination and its use for the treatment of diseases. The instant disclosure provides a combination of a so-called T-cell regulator selected from the group comprising PD1, PD-L1, OX40, TIM-3, LAG3, CD137(4-1BB) and a non-coding immunomodulating DNA.

Claim (Index 1):
A combination comprising the components of\n a. a first group comprising a chemical or molecule binding to at least one of the molecules selected from the group comprising PD1, PD-L1, OX40, TIM-3, LAG3, CD137(4-1BB) for affecting their function as T-cell regulators; and b. a second group comprising a non-coding sequence of deoxyribonucleic acids comprising at least one sequence motif N 1 N 2 CGN 3 N 4 , wherein N is a nucleotide comprising A, C, T, or G, and C is deoxycytidine, G is deoxyguanosine, A is deoxyadenosine and T is deoxythymidine.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.34211
- Patent Class: 536.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10057311', '14046044', '12442295', '11549048', '11743876']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6271273036058838
- 35 USC 102 Novelty (BERT): 0.5035468369387488
- Combined Prediction Score: 0.6147692569391703
- Mean Citation Score: 284.0886240000001
- Max Citation Score: 291.83954
- Similarity Product: 220.16211818853145

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test